ARMS2 and age-related macular degeneration: Similarly, for ARMS2 rs10490924 (GG, GT, and TT), we found a statistically significant difference between the exudative AMD and control groups, with frequencies of 31.8%, 43.3%, and 24,9%, compared to 54.3%, 38.3%, and 7.4% (p < 0.001).